Turkey Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 201...
- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop mark...
6 Overview of Key Companies in Turkey Diabetes Care Devices Market 566.1 F. Hoffmann-La Roche Ltd. 566.1.1 Company Overvie...
Table 3: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 13Table 4: Diabetes Care D...
Table 29: Insulin Delivery, Turkey, Average Price ($), Historic, 2004-2011 53Table 30: Insulin Delivery, Turkey, Average P...
Figure 23: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49Figure 24: Insulin Pumps (Traditiona...
Upcoming SlideShare
Loading in …5
×

Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

176 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
176
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

  1. 1. Turkey Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018Report Details:Published:September 2012No. of Pages: 67Price: Single User License – US$2500Turkey Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018SummaryGlobal Markets Direct’s new report, ”Turkey Diabetes Care Devices Investment Opportunities,Analysis and Forecasts to 2018”, provides key market data on the Turkey Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on key recent developments.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by Global Markets Direct’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Turkey Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Eli Lilly and Company, NovoNordisk A/S, LifeScan, Inc., Bayer HealthCare AG and others.Reasons to buy
  2. 2. - Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Turkey Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/195378-turkey-diabetes-care-devices-investment-opportunities-analysis-and-forecasts-to-2018.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 72.1 What is This Report About? 73 Diabetes Care Devices In Turkey 83.1 Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, 2004-2018 83.2 Diabetes Care Devices, Turkey, Company Share (2010-2011) 144 Glucose Monitoring In Turkey 164.1 Glucose Monitoring Overall Revenue, (2004-2018) 164.1.1 Blood Glucose Meters, Revenue (2004-2018) 204.2 Glucose Monitoring Overall Volume (2004-2018) 224.2.1 Blood Glucose Meters, Volume (2004-2018) 264.3 Glucose Monitoring Average Price (2004-2018) 284.4 Glucose Monitoring Distribution Share (2010-2011) 294.5 Glucose Monitoring, Turkey, Company Share (2010-2011) 305 Insulin Delivery In Turkey 325.1 Insulin Delivery Overall Revenue, (2004-2018) 325.1.1 Insulin Pens, Revenue (2004-2018) 365.1.2 Insulin Pumps, Revenue (2004-2018) 405.2 Insulin Delivery Overall Volume (2004-2018) 435.2.1 Insulin Pens, Volume (2004-2018) 475.2.2 Insulin Pumps, Volume (2004-2018) 515.3 Insulin Delivery Average Price (2004-2018) 535.4 Insulin Delivery Distribution Share (2010-2011) 545.5 Insulin Delivery, Turkey, Company Share (2010-2011) 55
  3. 3. 6 Overview of Key Companies in Turkey Diabetes Care Devices Market 566.1 F. Hoffmann-La Roche Ltd. 566.1.1 Company Overview 566.2 Sanofi 566.2.1 Company Overview 566.3 Eli Lilly and Company 576.3.1 Company Overview 576.4 Novo Nordisk A/S 576.4.1 Company Overview 576.5 LifeScan, Inc. 586.5.1 Company Overview 586.6 Bayer HealthCare AG 586.6.1 Company Overview 586.7 Becton, Dickinson and Company 586.7.1 Company Overview 586.8 Abbott Laboratories 596.8.1 Company Overview 596.9 Medtronic, Inc. 596.9.1 Company Overview 596.10 Terumo Corporation 606.10.1 Company Overview 606.11 Nipro Corporation 606.11.1 Company Overview 606.12 Terumo Corporation 616.12.1 Company Overview 617 Appendix 627.1 Global Markets Direct Research Methodology 627.2 Definitions of Markets Covered in the Report 637.2.1 Diabetes Care Devices 637.3 Secondary Research 657.4 Primary Research 657.5 Models 667.6 Forecasts 667.7 Expert Panel Validation 667.8 Currency Conversion 677.9 Contact Us 677.10 Disclaimer 671.1 List of TablesTable 1: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, 2004-2018 9Table 2: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Historic, 2004-2011 11
  4. 4. Table 3: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 13Table 4: Diabetes Care Devices, Turkey, Company Share by Revenue ($m), USD Constant, 2010-2011 15Table 5: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 17Table 6: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 19Table 7: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USDConstant, Historic, 2004-2011 20Table 8: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USDConstant, Forecast, 2011-2018 21Table 9: Glucose Monitoring, Turkey, Volume (Units) by Segment, Historic, 2004-2011 23Table 10: Glucose Monitoring, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 25Table 11: Blood Glucose Meters, Turkey, Volume (Units), Historic, 2004-2011 26Table 12: Blood Glucose Meters, Turkey, Volume (Units), Forecast, 2011-2018 27Table 13: Glucose Monitoring, Turkey, Average Price ($), Historic, 2004-2011 28Table 14: Glucose Monitoring, Turkey, Average Price ($), Forecast, 2011-2018 28Table 15: Glucose Monitoring, Turkey, Distribution Share by Revenue ($m), USD Constant, 2010-2011 29Table 16: Glucose Monitoring, Turkey, Company Share by Revenue ($m), USD Constant, 2010-2011 31Table 17: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-201133Table 18: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 35Table 19: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 37Table 20: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 39Table 21: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,Historic, 2004-2011 41Table 22: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,Forecast, 2011-2018 42Table 23: Insulin Delivery, Turkey, Volume (Units) by Segment, Historic, 2004-2011 44Table 24: Insulin Delivery, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 46Table 25: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Historic, 2004-2011 48Table 26: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50Table 27: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Historic, 2004-201151Table 28: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Forecast, 2011-201852
  5. 5. Table 29: Insulin Delivery, Turkey, Average Price ($), Historic, 2004-2011 53Table 30: Insulin Delivery, Turkey, Average Price ($), Forecast, 2011-2018 53Table 31: Insulin Delivery, Turkey, Distribution Share by Revenue ($m), USD Constant, 2010-201154Table 32: Insulin Delivery, Turkey, Company Share by Revenue ($m), USD Constant, 2010-2011551.2 List of FiguresFigure 1: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, 2004-2018 8Figure 2: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Historic, 2004-2011 10Figure 3: Diabetes Care Devices, Turkey, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 12Figure 4: Diabetes Care Devices, Turkey, Company Share (%), 2011 14Figure 5: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 16Figure 6: Glucose Monitoring, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 18Figure 7: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USDConstant, Historic, 2004-2011 20Figure 8: Blood Glucose Meters (Traditional Glucose Meters), Turkey, Revenue ($m) USDConstant, Forecast, 2011-2018 21Figure 9: Glucose Monitoring, Turkey, Volume (Units) by Segment, Historic, 2004-2011 22Figure 10: Glucose Monitoring, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 24Figure 11: Blood Glucose Meters, Turkey, Volume (Units), Historic, 2004-2011 26Figure 12: Blood Glucose Meters, Turkey, Volume (Units), Forecast, 2011-2018 27Figure 13: Glucose Monitoring, Turkey, Company Share (%), 2011 30Figure 14: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 32Figure 15: Insulin Delivery, Turkey, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 34Figure 16: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 36Figure 17: Insulin Pens, Turkey, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 38Figure 18: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,Historic, 2004-2011 40Figure 19: Insulin Pumps (Traditional Insulin Pumps), Turkey, Revenue ($m) USD Constant,Forecast, 2011-2018 42Figure 20: Insulin Delivery, Turkey, Volume (Units) by Segment, Historic, 2004-2011 43Figure 21: Insulin Delivery, Turkey, Volume (Units) by Segment, Forecast, 2011-2018 45Figure 22: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Historic, 2004-2011 47
  6. 6. Figure 23: Insulin Pens, Turkey, Volume (Units) by Sub-Segment, Forecast, 2011-2018 49Figure 24: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Historic, 2004-201151Figure 25: Insulin Pumps (Traditional Insulin Pumps), Turkey, Volume (Units), Forecast, 2011-2018 52Figure 26: Insulin Delivery, Turkey, Company Share (%), 2011 55Figure 27: Global Markets Direct Methodology 62Contact: sales@reportsandreports.com for more information.

×